AEON Biopharma AEON
NYSE AEON
$0.23 +0.00 (+1.26%)
As of: Oct 20, 2026 · 3:59 PM EDT

AEON Biopharma (AEON) Long-Term Debt Repayments (2021)

Updated

AEON Biopharma (AEON) recorded Long-Term Debt Repayments of $3.99 million in FY2022, compared with $73,780 in FY2021.

Analysis

AEON Biopharma (AEON) Long-Term Debt Repayments (2021) Analysis & Trends

  • Per Business Quant data, AEON's Long-Term Debt Repayments was $73,780 in FY2021.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Repayment (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 873.00 Mn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 1.00 Mn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 2.00 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 5.00 Mn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 20.00 Mn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 2.46 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn -
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 17.00 Mn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn -
10 AEON Biopharma 11.93 Mn -8.87 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 73,780.00
API Access

AEON Biopharma Long-Term Debt Repayments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-repayments&ticker=AEON&period=max&api_key=YOUR_API_KEY